Brief: Hyundai IBT to buy 24.5 pct stake in Vitabrid MENA Limited for 138.6 mln won
June 21 (Reuters) - Hyundai IBT Co Ltd 048410.KQ :
* Says it plans to buy 122,500 shares of Vitabrid MENA
Limited, a cosmetic sales firm, for 138.6 million won
* Says it will hold 24.5 percent stake(122,500 shares) in
target company after transaction
Source text in Korean: https://goo.gl/GZsTsm
Further company coverage: 048410.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Hyundai Bioscience Co
See all newsBrief: Hyundai Bioscience Announces Successful Result From Preclinical Study Of Niclosamide-Based Oral Anticancer Drug
S.Korean vaccine firm SK Bioscience sees shares soar 30% on debut (updated)
Vaccine developer SK Bioscience to raise $1.3 bln in S.Korea's largest IPO since 2017 (updated)
Brief: Hyundai Bioscience Develops Injection Drug For Potential Treatment Of Severe Cases Of COVID-19
Brief: Hyundai Bioscience Says Co's COVID-19 Oral Drug Solved Niclosamide's Inhibitory Concentration Problem